Tilray Medical a division of Tilray Brands, Inc., today announced the expansion of its Tilray Craft portfolio in Germany with five new cannabis flower products produced in Germany at Tilray’s EU‑GMP certified facility in Neumünster as part of the BfArM in‑country cultivation program. The additions reflect Tilray’s ongoing commitment to providing physicians and pharmacies with a diverse range of quality, EU‑GMP certified medical cannabis options for eligible patients.
Tilray Craft cannabis is cultivated and produced indoors at Tilray’s EU‑GMP certified facility located in Neumünster, Germany. The production process adheres to rigorous quality control standards and protocols, ensuring distinctive, quality medical cannabis that patients can depend on for consistency and reliability.
New Tilray Craft Products:
- Tilray Craft Cannabisblüten THC30 TRM (Triangle Mints)
- Tilray Craft Cannabisblüten THC28 TRM (Triangle Mints)
- Tilray Craft Cannabisblüten THC28 PPV (Platinum Pave 34)
- Tilray Craft Cannabisblüten THC25 PPV (Platinum Pave 34)
- Tilray Craft Cannabisblüten THC22 SNS (Sunset Sherbet)
All Tilray Craft products are available by prescription at pharmacies throughout Germany. Tilray remains dedicated to advancing medical cannabis innovation and supporting healthcare professionals with quality, compliant solutions. As patient needs continue to evolve, the company will responsibly expand its portfolio to ensure access to consistent, EU-GMP certified products both within Germany and internationally.
